CoreCap Advisors’s GoodRx Holdings GDRX Stock Holding History

CoreCap Advisors’s Portfolio GDRX Stock Details GDRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-5	Closed	-$36	–	1969
2024 Q1	$36	Buy	+5	New	+$33	﹤0.01%	2483
2022 Q4	$23	Buy	+5	New	+$25	﹤0.01%	2362
2022 Q3	–	Sell	-5	Closed	–	–	1116
2022 Q2	$0	Buy	+5	New	+$56	﹤0.01%	2185
2022 Q1	–	Sell	-5	Closed	-$1K	–	1122
2021 Q4	$1K	Buy	+5	New	+$201	﹤0.01%	2124

Other funds holding GDRX

FPM

Francisco Partners Management San Francisco, California $292M AUM 34.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

LCM

Lakewood Capital Management New York $1.58B AUM 0.92% 1-Year Est. Return

SLG

Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

PTC

Petrus Trust Company Dallas, Texas $915M AUM 2.95% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

CoreCap Advisors's GDRX Position: Q2 2024 in Review

CoreCap Advisors sold out of GoodRx Holdings (GDRX) in Q2 2024, closing a stake of 5 shares — an estimated $36 sold.

CoreCap Advisors first reported a position in GDRX in Q4 2021 and held it in 4 quarters. The position peaked at $1K in Q4 2021. 165 funds tracked by Wall St. Rank hold GDRX as of Q2 2024.

CoreCap Advisors reported no remaining GoodRx Holdings position as of Q2 2024 after selling out during the quarter.
CoreCap Advisors sold 5 GoodRx Holdings shares in Q2 2024, an estimated $36.
CoreCap Advisors first reported a position in GoodRx Holdings in Q4 2021 and held it in 4 quarters.
CoreCap Advisors's GoodRx Holdings position peaked at $1K in Q4 2021.
165 funds tracked by Wall St. Rank held GoodRx Holdings as of Q2 2024.

Based on CoreCap Advisors's 13F filing for Q2 2024, filed 8 Aug 2024.